Sysmex (OTCMKTS:SSMXY) Shares Gap Down – What’s Next?

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY) gapped down before the market opened on Thursday . The stock had previously closed at $10.00, but opened at $9.30. Sysmex shares last traded at $9.50, with a volume of 8,086 shares traded.

Sysmex Price Performance

The company has a current ratio of 3.34, a quick ratio of 2.49 and a debt-to-equity ratio of 0.11. The stock’s fifty day moving average price is $9.72 and its 200-day moving average price is $11.33. The firm has a market cap of $5.36 billion, a price-to-earnings ratio of 17.75 and a beta of 1.14.

Sysmex (OTCMKTS:SSMXY) last announced its quarterly earnings data on Thursday, February 12th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.01. The business had revenue of $837.32 million during the quarter, compared to analyst estimates of $819.99 million. Sysmex had a return on equity of 9.32% and a net margin of 8.86%. As a group, equities research analysts forecast that Sysmex Corporation ADR will post 0.57 earnings per share for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.